Page Title
Clinical Trial Finder
Observational Closed to Enrollment
Porcine viral antibody point prevalence study in people with CF taking pancreatic enzymes (AbbVie JSPP-12-01)
This observational study will look at the prevalence of antibodies to hepatitis E virus (HEV) and other selected porcine viruses in people with cystic fibrosis who are receiving pancreatic enzyme replacement therapy (PERT). Data from people with CF receiving PERT will be compared to a control group who have a chronic disease, are not taking PERT, and are matched for age and geographic region of residence. Data collection will include demographic and medical history, PERT therapy, transfusion history, and history of potential exposure to pig viruses. This study is for people with CF who are receiving PERT. It may require blood draws and/or other measurements. This harmonized protocol reflects equal sponsorship not only by the registering Sponsor, AbbVie, but also the Collaborators, Aptalis Pharma and Janssen Research & Development, LLC.
Eligibility
-
Age:
2 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
1 days -
Number of Study Visits:
1
Additional Information
-
Phase: ?more info
Phase Four/Post-Approval -
Study Sponsor: ?more info
AbbVie -
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
Alaska
Providence Alaska Medical Center, Anchorage, AK 99508
-
Closed to Enrollment
Arkansas
Arkansas Children's Hospital, Little Rock, AR 72202
-
Closed to Enrollment
California
Children's Hospital of Los Angeles, Los Angeles, CA 90027
-
Closed to Enrollment
California
Miller Children's and Women's Hospital Long Beach, Long Beach, CA 90806
-
Closed to Enrollment
California
Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles, CA 90033
-
Closed to Enrollment
California
Kaiser Permanente Southern California CF Center, Los Angles, CA 90027
-
Closed to Enrollment
Connecticut
Yale University School of Medicine, New Haven, CT 06520
-
Closed to Enrollment
Connecticut
Central Connecticut Cystic Fibrosis Center, Hartford, CT 06106
-
Closed to Enrollment
Florida
Central Florida Pulmonary Group, Orlando, FL 32803
-
Closed to Enrollment
Florida
Tampa General Hospital, Tampa, FL 33606
-
Closed to Enrollment
Georgia
Children's Healthcare of Atlanta at Scottish Rite, Atlanta, GA 30329
-
Closed to Enrollment
Idaho
Saint Luke's Cystic Fibrosis Center of Idaho, Boise, ID 83702
-
Closed to Enrollment
Illinois
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL 60611
-
Closed to Enrollment
Illinois
OSF HealthCare Children’s Hospital of Illinois, Saint Francis Medical Center, Peoria, IL 61637
-
Closed to Enrollment
Indiana
Indiana University Medical Center, Indianapolis, IN 46202
-
Closed to Enrollment
Kansas
Via Christi, Saint Francis Campus, Wichita, KS 67214
-
Closed to Enrollment
Louisiana
Tulane University, Metairie, LA 70001
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
Corewell Health Helen DeVos, Grand Rapids , MI 49503
-
Closed to Enrollment
Nebraska
University of Nebraska Medical Center, Omaha, NE 68114
-
Closed to Enrollment
New York
The Cystic Fibrosis Center of Western New York, Buffalo, NY 14203
-
Closed to Enrollment
New York
Long Island Jewish Medical Center, New Hyde Park, NY 11042
-
Closed to Enrollment
New York
SUNY Upstate Medical University, Syracuse, NY 13210
-
Closed to Enrollment
New York
Cohen Children's Medical Center of New York, New Hyde Park, NY 11042
-
Closed to Enrollment
Ohio
Toledo Children's Hospital, Toledo, OH 43606
-
Closed to Enrollment
Ohio
University of Cincinnati Medical Center, Cincinnati, OH 45267
-
Closed to Enrollment
Ohio
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center, Cleveland, OH 44106
-
Closed to Enrollment
Oklahoma
Oklahoma Cystic Fibrosis Center, OKC, OK 73104
-
Closed to Enrollment
Pennsylvania
University of Pennsylvania, Philadelphia, PA 19104
-
Closed to Enrollment
Pennsylvania
St. Christopher's Hospital for Children, Philadelphia, PA 19134
-
Closed to Enrollment
South Dakota
Sanford USD Medical Center, Sioux Falls, SD 57117
-
Closed to Enrollment
Tennessee
East Tennessee Children's Hospital, Knoxville, TN 37916
-
Closed to Enrollment
Texas
University of Texas Health Center at Tyler, Tyler, TX 75708
-
Closed to Enrollment
Texas
Baylor College of Medicine, Houston, TX 77030
-
Closed to Enrollment
Vermont
University of Vermont Medical Center, Burlington, VT 05401
-
Closed to Enrollment
Vermont
Vermont Children's Hospital, Burlington, VT 05401
-
Closed to Enrollment
Virginia
Virginia Commonwealth University, Richmond, VA 23219
-
Closed to Enrollment
West Virginia
West Virginia University - Morgantown, Morgantown, WV 26507
-
Closed to Enrollment
Wisconsin
University of Wisconsin, Madison, WI 53792
Eligibility
-
Age:
2 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More